Dow Jones

40,211.72

0.00%

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

CTMX

CytomX Therapeutics (CTMX)

CytomX Therapeutics Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CTMX

<< Anterior 1 2 3 4 5 6 7 8 9 10 11

Fecha	Hora	Fuente	Título	Símbolo	Compañía
12/02/2016	08:08	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CTMX	CytomX Therapeutics Inc
11/02/2016	08:17	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:CTMX	CytomX Therapeutics Inc
25/01/2016	07:46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
20/01/2016	08:18	Dow Jones News	Bristol-Myers Selects 3rd CytomX Cancer Therapy Candidate	NASDAQ:CTMX	CytomX Therapeutics Inc
20/01/2016	07:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTMX	CytomX Therapeutics Inc
20/01/2016	07:00	GlobeNewswire Inc.	CytomX Announces Third Target Selection by Bristol-Myers Squibb, Triggering Milestone	NASDAQ:CTMX	CytomX Therapeutics Inc
18/12/2015	15:57	GlobeNewswire Inc.	CytomX Added to Russell 2000® Index	NASDAQ:CTMX	CytomX Therapeutics Inc
11/12/2015	07:00	GlobeNewswire Inc.	CytomX Selects Probody Drug Conjugate Clinical Candidate, CX-2009, Targeting Highly Expressed Tumor Antigen, CD166	NASDAQ:CTMX	CytomX Therapeutics Inc
01/12/2015	07:00	GlobeNewswire Inc.	CytomX to Present at Oppenheimer's 26th Annual Healthcare Conference	NASDAQ:CTMX	CytomX Therapeutics Inc
23/11/2015	07:00	GlobeNewswire Inc.	CytomX Reports Third Quarter 2015 Financial Results	NASDAQ:CTMX	CytomX Therapeutics Inc
23/11/2015	05:06	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CTMX	CytomX Therapeutics Inc
08/11/2015	17:30	PR Newswire (US)	CytomX Highlights Data from Multiple Probody Pipeline Programs at Investor Event During AACR-NCI-EORTC Conference	NASDAQ:CTMX	CytomX Therapeutics Inc
05/11/2015	15:05	PR Newswire (US)	CytomX and MD Anderson Cancer Center Enter Into Strategic Collaboration for Probody-Enabled CAR-NK Cell Therapies	NASDAQ:CTMX	CytomX Therapeutics Inc
03/11/2015	07:00	PR Newswire (US)	CytomX Appoints Matthew Young to Board of Directors	NASDAQ:CTMX	CytomX Therapeutics Inc
30/10/2015	14:08	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:CTMX	CytomX Therapeutics Inc
26/10/2015	16:41	PR Newswire (US)	/C O R R E C T I O N -- CytomX Therapeutics/	NASDAQ:CTMX	CytomX Therapeutics Inc
26/10/2015	15:30	PR Newswire (US)	Data from CytomX's Probody™ Pipeline to be Presented at the 2015 AACR-NCI-EORTC International Conference on Molecular Targe...	NASDAQ:CTMX	CytomX Therapeutics Inc
14/10/2015	14:00	PR Newswire (US)	CytomX Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares	NASDAQ:CTMX	CytomX Therapeutics Inc
08/10/2015	16:07	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	NASDAQ:CTMX	CytomX Therapeutics Inc
08/10/2015	15:33	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CTMX	CytomX Therapeutics Inc
08/10/2015	13:37	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:CTMX	CytomX Therapeutics Inc
08/10/2015	05:01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CTMX	CytomX Therapeutics Inc
06/10/2015	15:55	Edgar (US Regulatory)	Securities Registration (section 12(b)) (8-a12b)	NASDAQ:CTMX	CytomX Therapeutics Inc
06/10/2015	14:43	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:CTMX	CytomX Therapeutics Inc